Literature DB >> 9223454

STRL22 is a receptor for the CC chemokine MIP-3alpha.

F Liao1, R Alderson, J Su, S J Ullrich, B L Kreider, J M Farber.   

Abstract

STRL22 is a human seven transmembrane domain orphan receptor related to known chemokine receptors and expressed in peripheral blood lymphocytes, tumor infiltrating lymphocytes and lymphoid tissues. MIP-3alpha/LARC/Exodus is a CC chemokine that is chemotactic for lymphocytes and that is expressed in activated cells, including monocytes, T cells, endothelial cells, and fibroblasts, and in liver, lung, and some lymphoid tissues. We report here that STRL22-transfected human embryonic kidney 293 cells demonstrated specific binding for MIP-3alpha and that MIP-3alpha, but no other chemokines, produced a calcium flux in the STRL22-transfected cells. We show that MIP-3alpha, unlike other chemokines, produced a calcium flux in freshly-isolated peripheral blood lymphocytes and we show that MIP-3alpha also produced a signal in tumor infiltrating lymphocytes that express STRL22. Since STRL22 is the sixth functional CC chemokine receptor identified, it should be re-named CCR6.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223454     DOI: 10.1006/bbrc.1997.6936

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  CCR6-deficient mice have impaired leukocyte homeostasis and altered contact hypersensitivity and delayed-type hypersensitivity responses.

Authors:  R Varona; R Villares; L Carramolino; I Goya ; A Zaballos ; J Gutiérrez; M Torres; C Martínez-A; G Márquez
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype.

Authors:  Kazuya Kitamura; Joshua M Farber; Brian L Kelsall
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

4.  CCR6 promotes steady-state mononuclear phagocyte association with the intestinal epithelium, imprinting and immune surveillance.

Authors:  Keely G McDonald; Leroy W Wheeler; Jeremiah R McDole; Shannon Joerger; Jenny K Gustafsson; Devesha H Kulkarni; Kathryn A Knoop; Ifor R Williams; Mark J Miller; Rodney D Newberry
Journal:  Immunology       Date:  2017-08-30       Impact factor: 7.397

5.  The chemokine CCL20 induces proinflammatory and matrix degradative responses in cartilage.

Authors:  Nada Alaaeddine; John Antoniou; Mayssam Moussa; George Hilal; Gaby Kreichaty; Ismat Ghanem; Wissam Abouchedid; Elie Saghbini; John A Di Battista
Journal:  Inflamm Res       Date:  2015-07-20       Impact factor: 4.575

Review 6.  CCR6 as a possible therapeutic target in psoriasis.

Authors:  Michael N Hedrick; Anke S Lonsdorf; Sam T Hwang; Joshua M Farber
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

7.  Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis.

Authors:  T Matsui; T Akahoshi; R Namai; A Hashimoto; Y Kurihara; M Rana; A Nishimura; H Endo; H Kitasato; S Kawai; K Takagishi; H Kondo
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

8.  Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Authors:  H-F Dong; K Wigmore; M N Carrington; M Dean; J A Turpin; O M Z Howard
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

9.  Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.

Authors:  Fiorenza Cocchi; Anthony L DeVico; Wuyuan Lu; Mikulas Popovic; Olga Latinovic; Mohammad M Sajadi; Robert R Redfield; Mark K Lafferty; Massimo Galli; Alfredo Garzino-Demo; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

10.  Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype typhimurium infection.

Authors:  Sebastian E Winter; Parameth Thiennimitr; Sean-Paul Nuccio; Takeshi Haneda; Maria G Winter; R Paul Wilson; Joseph M Russell; Thomas Henry; Quynh T Tran; Sara D Lawhon; Gabriel Gomez; Charles L Bevins; Holger Rüssmann; Denise M Monack; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.